Pavel Ryzhov
Biopharma Morning Coffee
Exactly what it means - get a cup of coffee, listen to a brief rundown of latest biopharma news - but not just in a "here's what happened" way - get extra insights WHY these news matter.
Be sure to visit the podcast's website and support the creator: rss.com
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Install for free
Android almost 10M downloads · 4.8 rating
iOS soon
Episodes
Biopharma Morning Coffee – Weekly Brief February 26, 2026 26.02.2026 10:13
Gilead's $7.8B acquisition of Arcellx and its CAR-T therapy anito-cel headlines this week — a PDUFA date of December 2026 signals a major cell therapy outsourcing wave ahead. The FDA also launched its bespoke gene therapy pathway, opening a new regulatory road for gene editing and RNA-based rare disease treatments. Plus: the GLP-1 war heats up as Novo's CagriSema falls to Zepbound, Pfizer licenses...
Similar podcasts
Listen to the Biopharma Morning Coffee podcast in Replaio
Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.
